These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18062330)

  • 21. Pregabalin: a treatment for fibromyalgia and other painful conditions.
    Smith SM
    Nurs Womens Health; 2008 Oct; 12(5):432-5. PubMed ID: 18837723
    [No Abstract]   [Full Text] [Related]  

  • 22. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregabalin for fibromyalgia: some relief but no cure.
    Kim L; Lipton S; Deodhar A
    Cleve Clin J Med; 2009 Apr; 76(4):255-61. PubMed ID: 19339642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of pregabalin intoxication.
    Miljevic C; Crnobaric C; Nikolic S; Lecic-Tosevski D
    Psychiatriki; 2012; 23(2):162-5. PubMed ID: 22796916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregabalin: its efficacy, safety and tolerability profile in fibromyalgia syndrome.
    Owen RT
    Drugs Today (Barc); 2007 Dec; 43(12):857-63. PubMed ID: 18174971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pregabalin in the treatment of neuropathic pain].
    Biegstraaten M; van Schaik IN
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1561-5. PubMed ID: 17715763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I; Wajsbrot D; Therrien F; Lemay J
    Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pregabalin (Lyrica) and neuropathic pain syndromes].
    Jacquy J; Lossignol D; Sternon J
    Rev Med Brux; 2006; 27(5):445-50. PubMed ID: 17144644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
    Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
    Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of neuropathy-induced allodynia following intraplantar injection of pregabalin.
    Park HJ; Joo HS; Chang HW; Lee JY; Hong SH; Lee Y; Moon DE
    Can J Anaesth; 2010 Jul; 57(7):664-71. PubMed ID: 20440664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin for neuropathic pain based on recent clinical trials.
    Stacey BR; Swift JN
    Curr Pain Headache Rep; 2006 Jun; 10(3):179-84. PubMed ID: 18778571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review.
    Page RL; Cantu M; Lindenfeld J; Hergott LJ; Lowes BD
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):922-5. PubMed ID: 18695430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.